Amended Statement of Ownership (sc 13g/a)
18 Gennaio 2022 - 10:55PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
13G/A
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT
NO. 1)
ENVERIC
BIOSCIENCES, INC. f/k/a AMERI Holdings, Inc.
(Name
of Issuer)
COMMON
STOCK
(Title
of Class of Securities)
02362F104
(CUSIP
Number)
December
31, 2021
(DATE
OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(c)
|
|
*
|
The
remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover
page.
|
The
information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of
the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the Notes).
(Continued
on following page(s)
Page
1 of 5 Pages
|
CUSIP No. 02362F104
|
|
13G
|
Page
2 of 5 Pages
|
|
1.
|
NAMES OF REPORTING PERSON
|
|
|
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
|
|
|
|
|
Alpha Capital
Anstalt
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
|
|
(a) ☐
|
|
|
(b) ☐
|
|
3.
|
SEC USE ONLY
|
|
|
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
Liechtenstein
|
|
5.
|
SOLE
VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON – 2,317,163 Shares of Common
Stock (1)
|
|
|
|
|
6.
|
SHARED VOTING POWER – None
|
|
|
|
|
7.
|
SOLE
DISPOSITIVE POWER – 2,317,163 Shares of Common Stock (1)
|
|
|
|
|
8.
|
SHARED DISPOSITIVE POWER – None
|
|
|
|
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON -
|
|
|
|
|
|
|
|
2,317,163
Shares of Common Stock (1)
|
|
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
|
|
|
|
CERTAIN SHARES
|
☐
|
|
|
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
|
|
|
|
|
|
|
7.383%
(1)
|
|
|
12.
|
TYPE OF REPORTING PERSON
|
|
|
|
|
|
|
|
CO
|
|
|
|
(1)
|
Based
on 31,383,632 shares outstanding as of November 15, 2021 as disclosed in Form 10-Q filed
on November 15, 2021 for the quarter ended September 30, 2021.
|
|
CUSIP No. 02362F104
|
|
13G
|
Page
3 of 5 Pages
|
ITEM 1 (a) NAME OF ISSUER: Enveric Biosciences, Inc. f/k/a AMERI Holdings,
Inc., a Delaware corporation
ITEM 1 (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
4851 Tamiami Trail N, Suite 200, Naples, FL 34103
ITEM 2 (a) NAME OF PERSON FILING: Alpha Capital Anstalt
ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
Altenbach 8, FL-9490 Vaduz, Liechtenstein
ITEM 2 (c) CITIZENSHIP: Liechtenstein
ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Stock
ITEM 2 (e) CUSIP NUMBER: 02362F104
ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B):
Not applicable
ITEM 4 OWNERSHIP
(a) AMOUNT BENEFICIALLY OWNED: 2,317,163 Shares
of Common Stock (1)
(b) PERCENT OF CLASS: 7.383% (1)
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) SOLE POWER TO VOTE OR DIRECT THE VOTE
2,317,163 Shares of Common Stock (1)
(ii) SHARED POWER TO VOTE OR DIRECT THE VOTE
0 Shares
(iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION
OF
2,317,163 Shares of Common Stock (1)
(iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION
OF
0 Shares
|
CUSIP No. 02362F104
|
|
13G
|
Page
4 of 5 Pages
|
ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable
ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable
ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable
ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP
Not applicable
ITEM 9 NOTICE OF DISSOLUTION OF GROUP
Not applicable
|
CUSIP No. 02362F104
|
|
13G
|
Page
5 of 5 Pages
|
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
January 18, 2022
|
|
|
(Date)
|
|
|
|
|
|
/s/ Konrad Ackermann
|
|
|
(Signature)
|
|
|
|
|
|
Konrad Ackermann, Director
|
|
|
(Name/Title)
|
Grafico Azioni Ameri (NASDAQ:AMRH)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Ameri (NASDAQ:AMRH)
Storico
Da Feb 2024 a Feb 2025
